On October 4, the PMDA held the “PMDA-ATC Pharmacovigilance Webinar for the National Pharmaceutical Regulatory Agency (NPRA), Malaysia.”
The theme of the webinar was pharmacovigilance. The PMDA shared information on the Japanese regulatory system and PMDA’s experiences with 41 NPRA regulators engaging in pharmacovigilance and related areas.
The PMDA continues to conduct seminars and strengthen collaboration with NPRA.
See attached program[68.7 KB].
Back
Back
-
Regulations & Services of PMDAInformation about Approved Products in JapanSafety InformationAdvanced Efforts
-
Information for approved products in JapanSafety information
-
Development of Drugs, Medical devices, Regenerative medicines and in Vitro diagnosticsInformation for approved products in JapanRegulatory science
-
Regulations and services of PMDAInformation for approved products in JapanProcedures in JapanAdvanced efforts
Back
-
Regulations and Services of PMDAInformation for apporoved products in JapanSafety informationProcedures in Japan
-
Regulations and Services of PMDAInformation for apporoved products in JapanSafety informationProcedures in Japan
-
Reviews and Related ServicesRegulatory ProceduresPost-marketing Safety Measures
-
Reviews and Related ServicesPost-marketing Safety Measures
- Home
- Events and Symposia
- Report of the PMDA-ATC Pharmacovigilance Webinar for NPRA, Malaysia
Events and Symposia